A novel transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma: A prospective randomized trial

Journal of Gastroenterology

Volumn 46, Issue 3, 2011, Pages 359-366

  Yamasaki, Takahiro ^a   Hamabe, Satoe ^a   Saeki, Issei ^a   Harima, Yohei ^a   Yamaguchi, Yuhki ^a   Uchida, Koichi ^a   Terai, Shuji ^a   Sakaida, Isao ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Degradable starch microspheres; Hepatocellular carcinoma; Iodized oil; Randomized trial; Transcatheter arterial infusion chemotherapy

Indexed keywords

CISPLATIN; IA CALL; IODINATED POPPYSEED OIL; LIPIODOL ULTRA FLUID; STARCH MICROSPHERE; UNCLASSIFIED DRUG;

AGED; ANOREXIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES; BILOMA; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIARRHEA; DRUG FATALITY; DRUG FEVER; DRUG RESPONSE; FATIGUE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LUNG EMBOLISM; MALE; NAUSEA; PLEURA EFFUSION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TUMOR VOLUME; ULCER;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; DISEASE-FREE SURVIVAL; ETHIODIZED OIL; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STARCH; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79954420892     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0306-5     Document Type: Article

References (45)

1. F Kamangar GM Dores WF Anderson 2006 Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2137 2150 16682732 10.1200/JCO.2005.05.2308 (Pubitemid 46655601)
2. K Kiyosawa T Umemura T Ichijo A Matsumoto K Yoshizawa A Gad, et al. 2004 Hepatocellular carcinoma: recent trends in Japan Gastroenterology 127 S17 S26 15508082 10.1053/j.gastro.2004.09.012 (Pubitemid 39423366)
3. HB El-Serag 2004 Hepatocellular carcinoma: recent trends in the United States Gastroenterology 127 S27 S34 15508094 10.1053/j.gastro.2004.09.013 (Pubitemid 39423367)
4. C Bosetti F Levi P Boffetta F Lucchini E Negri C La Vecchia 2008 Trends in mortality from hepatocellular carcinoma in Europe. 1980-2004 Hepatology 48 137 145 18537177 10.1002/hep.22312 (Pubitemid 351980469)
5. HB El-Serag JA Marrero L Rudolph KR Reddy 2008 Diagnosis and treatment of hepatocellular carcinoma Gastroenterology 134 1752 1763 18471552 10.1053/j.gastro.2008.02.090 (Pubitemid 351615415)
6. M Ebara S Okabe K Kita N Sugiura H Fukuda M Yoshikawa, et al. 2005 Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation J Hepatol 43 458 464 16005538 10.1016/j.jhep.2005.03.033 1:CAS:528:DC%2BD2MXntVCku7w%3D (Pubitemid 41111427)
7. O Matsui M Kadoya J Yoshikawa T Gabata K Arai H Demachi, et al. 1993 Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization Radiology 188 79 83 8390073 1:STN:280:DyaK3s3ovV2jtA%3D%3D (Pubitemid 23183103)
8. T Yamasaki F Kurokawa H Shirahashi N Kusano K Hironaka K Okita 2001 Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance for patients with hepatocellular carcinoma Cancer 91 1342 1348 11283935 10.1002/1097-0142(20010401)91:7<1342::AID- CNCR1137>3.0.CO;2-0 1:STN:280:DC%2BD3M3js1ygtw%3D%3D (Pubitemid 32267046)
9. S Todo H Furukawa Japanese Study Group on Organ Transplantation 2004 Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan Ann Surg 240 451 461 15319716 10.1097/01.sla.0000137129.98894.42 (Pubitemid 39121339)
10. JM Llovet S Ricci V Mazzaferro P Hilgard E Gane JF Blanc, et al. 2008 Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378 390 18650514 10.1056/NEJMoa0708857 1:CAS:528:DC%2BD1cXovFWjsL8%3D
11. K Takayasu S Arii I Ikai M Omata K Okita T Ichida, et al. 2006 Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients Gastroenterology 131 461 469 16890600 10.1053/j.gastro.2006.05.021 1:CAS:528:DC%2BD28XpsFyks7Y%3D (Pubitemid 44142456)
12. L Marelli R Stigliano C Triantos M Senzolo E Cholongitas N Davies, et al. 2007 Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 6 25 17103105 10.1007/s00270-006-0062-3 (Pubitemid 44900485)
13. J Bruix JM Llovet A Castells X Montañá C Brú MC Ayuso, et al. 1998 Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution Hepatology 27 1578 1583 9620330 10.1002/hep.510270617 1:STN:280:DyaK1c3otFKnsg%3D%3D (Pubitemid 28264682)
14. G Pelletier M Ducreux F Gay M Luboinski H Hagège D Thong, et al. 1998 Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial J Hepatol 29 129 134 9696501 10.1016/S0168-8278(98)80187-6 1:CAS:528:DyaK1cXmvVWhsLk%3D (Pubitemid 28307992)
15. C Cammà F Schepis A Orlando M Albanese L Shahied F Trevisani, et al. 2002 Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 47 54 12091661 10.1148/radiol.2241011262 (Pubitemid 34680374)
16. JM Llovet J Bruix 2003 Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 429 442 12540794 10.1053/jhep.2003.50047 1:CAS:528: DC%2BD3sXhsFeltrg%3D (Pubitemid 36152543)
17. K Takayasu Y Muramatsu T Maeda R Iwata H Furukawa N Moriyama, et al. 2001 Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates AJR Am J Roentgenol 176 681 688 11222205 1:STN:280:DC%2BD3M3is1Kkug%3D%3D (Pubitemid 32181966)
18. HJ Yoon JH Kim KA Kim IS Lee GY Ko HY Song, et al. 2010 Transcatheter arterial chemo-lipiodol infusion for unresectable hepatocellular carcinoma in 96 high-risk patients Clin Radiol 65 271 277 20338393 10.1016/j.crad.2010.01.018
19. M Ikeda S Maeda J Shibata R Muta H Ashihara M Tanaka, et al. 2004 Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma Oncology 66 24 31 15031595 10.1159/000076331 1:CAS:528:DC%2BD2cXitlyitLo%3D (Pubitemid 38410676)
20. JO Forsberg 1978 Transient blood flow reduction induced by intra-arterial injection of degradable starch microspheres. Experiments on rats Acta Chir Scand 144 275 281 735662 1:CAS:528:DyaE1MXhsVKgtbo%3D (Pubitemid 9071669)
21. B Lindell KF Aronsen U Rothman 1977 Repeated arterial embolization of rat livers by degradable microspheres Eur Surg Res 9 347 356 923601 10.1159/000127954 1:CAS:528:DyaE1cXksFKlug%3D%3D (Pubitemid 8212201)
22. S Dakhil W Ensminger K Cho J Niederhuber K Doan R Wheeler 1982 Improved regional selectivity of hepatic arterial BCNU with degradable microspheres Cancer 50 631 635 7046907 10.1002/1097-0142(19820815)50:4<631::AID- CNCR2820500403>3.0.CO;2-M 1:STN:280:DyaL383jtlemuw%3D%3D (Pubitemid 12052707)
23. WD Ensminger JW Gyves P Stetson S Walker-Andrews 1985 Phase I study of hepatic arterial degradable starch microspheres and mitomycin Cancer Res 45 4464 4467 3928157 1:STN:280:DyaL2M3ot1egug%3D%3D (Pubitemid 16224914)
24. T Taguchi 1994 Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres Clin Pharmacokinet 26 275 291 8013161 10.2165/00003088-199426040-00004 1:CAS:528:DyaK2cXksVanuro%3D (Pubitemid 24116206)
25. BI Carr A Zajiko K Bron P Orons J Sammon R Baron 1997 Phase II study of Spherex (degradable starch microspheres) injected into the hepatic artery in conjunction with doxorubicin and cisplatin in the treatment of advanced-stage hepatocellular carcinoma: interim analysis Semin Oncol 24 Suppl 6 S6-97 S6-99
26. J Furuse H Ishii M Satake H Onaya H Nose S Mikami, et al. 2003 Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma Am J Clin Oncol 26 159 164 12714888 10.1097/00000421-200304000-00012 1:CAS:528:DC%2BD3sXntV2jtLg%3D (Pubitemid 36443559)
27. TD Kirchhoff KL Rudolph G Layer A Chavan TF Greten H Rosenthal, et al. 2006 Chemoocclusion vs. chemoperfusion for treatment of advanced hepatocellular carcinoma: a randomised trial Eur J Surg Oncol 32 201 207 16373084 10.1016/j.ejso.2005.11.003 1:STN:280:DC%2BD287gtlCjug%3D%3D (Pubitemid 43257124)
28. T Yamasaki I Saeki Y Harima K Okita M Segawa Y Yamaguchi, et al. 2008 The pilot study: a novel transarterial chemoembolization using degradable starch microspheres for hepatocellular carcinoma (in Japanese with English abstract) Kanzo 49 25 27 10.2957/kanzo.49.25
29. MM Oken RH Creech DC Tormey J Horton TE Davis ET McFadden, et al. 1982 Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 649 655 7165009 10.1097/00000421-198212000-00014 1:STN:280:DyaL3s7kvFOgsw%3D%3D (Pubitemid 13149996)
30. Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 5th edn. Tokyo: Kanehara, 2009 (in Japanese).
31. M Kudo H Chung Y Osaki 2003 Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score) J Gastroenterol 38 207 215 12673442 10.1007/s005350300038 (Pubitemid 36527122)
32. M Kanematsu H Hoshi T Imaeda T Murakami Y Inaba R Yokoyama, et al. 1997 Detection and characterization of hepatic tumors: value of combined helical CT hepatic arteriography and CT during arterial portography AJR Am J Roentgenol 168 1193 1198 9129410 1:STN:280:DyaK2s3nsFKnsg%3D%3D (Pubitemid 27183791)
33. T Okusaka S Okada H Ishii M Ikeda H Nakasuka H Nagahama, et al. 1998 Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma Oncology 55 276 283 9663415 10.1159/000011863 1:CAS:528: DyaK1cXktVejsrs%3D (Pubitemid 28279667)
34. K Takayasu S Arri N Matsuo M Yoshikawa M Ryu K Takasaki, et al. 2000 Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma AJR Am J Roentgenol 175 699 704 10954453 1:STN:280:DC%2BD3cvnsFartA%3D%3D
35. T Okusaka S Okada H Ueno M Ikeda M Yoshimori K Shimada, et al. 2000 Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma Oncology 58 293 299 10838494 10.1159/000012115 1:STN:280:DC%2BD3c3pvFajtQ%3D%3D (Pubitemid 30265338)
36. National Cancer Institute (2009) Common Terminology Criteria for Adverse Events v.4.0. National Cancer Institute, Bethesda
37. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observation J Am Stat Assoc 53 457 481 10.2307/2281868
38. Y Ono T Yoshimasu R Ashikaga M Inoue H Shindou K Fuji, et al. 2000 Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma Am J Clin Oncol 23 564 568 11202797 10.1097/00000421-200012000-00006 1:STN:280:DC%2BD3M7gvVKnsA%3D%3D (Pubitemid 32429101)
39. M Yoshikawa N Ono H Yodono T Ichida H Nakamura 2008 Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma Hepatol Res. 38 474 483 18430093 10.1111/j.1872-034X. 2008.00338.x 1:CAS:528:DC%2BD1cXptlajsLw%3D (Pubitemid 351593948)
40. Vogl TJ, Trapp M, Shroeder H, Mack M, Schuster A, Schmitt J, et al. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology. 2000;214:349-57. (Pubitemid 30077688)
41. TD Kirchhoff JS Bleck A Dettmer A Chavan H Rosenthal S Merkesdal, et al. 2007 Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival Hepatobiliary Pancreat Dis Int 6 259 266 17548248 1:CAS:528:DC%2BD2sXns1Kgtb0%3D (Pubitemid 46925246)
42. Kanematsu M. Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-lipiodol emulsion (EMILE) for hepatocellular carcinoma. J Gastroenterol. 1995;30:215-23.
43. ER Sigurdson JA Ridge JM Daly 1986 Intra-arterial infusion of doxorubicin with degradable starch microspheres. Improvement of hepatic tumor drug uptake Arch Surg 121 1277 1281 3778200 10.1001/archsurg.121.11.1277 1:STN:280:DyaL2s%2FkvVWhtQ%3D%3D (Pubitemid 17180513)
44. H Nakamura T Hashimoto H Oi S Sawada 1988 Iodized oil in the portal vein after arterial embolization Radiology 167 415 417 2833765 1:STN:280: DyaL1c7ptVekug%3D%3D
45. Z Kan K Ivancev I Hägerstrand VP Chuang A Lunderquist 1989 In vivo microscopy of the liver after injection of Lipiodol into the hepatic artery and portal vein in the rat Acta Radiol 30 419 425 2550044 10.3109/02841858909174710 1:STN:280:DyaL1MznsFSiug%3D%3D (Pubitemid 19225736)